Avita Medical share price on watch after being added to the ASX 200

The Avita Medical Ltd (ASX:AVH) share price could be on the rise today after the medical technology company was added to the ASX 200 index…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Avita Medical Ltd (ASX: AVH) share price could push higher on Friday after it became the latest addition to the ASX 200 index.

Why is Avita Medical joining the ASX 200?

After the market close on Thursday, S&P Dow Jones Indices announced that it will remove Aveo Group (ASX: AOG) from the S&P/ASX 200 on November 14.

This is because earlier in the week the retirement communities company's shareholders voted in favour of the scheme of arrangement that will see Brookfield Asset Management Inc acquire 100% of Aveo.

Brookfield Asset Management will pay a total consideration of $2.195 per share to Aveo shareholders. This is inclusive of the FY 2019 final distribution of 4.5 cents per security.

Whilst there were a good number of candidates to replace Aveo in the benchmark index, S&P Dow Jones Indices elected to choose Avita Medical.

This caps off a remarkable year for Avita Medical and its shareholders. On January 1 the medical technology company's shares were largely under the radar of most investors and changing hands at just 8 cents. Now they are trading 719% higher at 65.5 cents, giving it a market capitalisation of ~$1.2 billion.

What is Avita Medical?

Avita Medical is a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration.

The company's FDA-approved RECELL System is indicated for use in the treatment of acute thermal burns in patients 18 years and older. It is used to prepare Spray-On Skin Cells using a small amount of a patient's own skin. This provides a new way to treat severe burns, while significantly reducing the amount of donor skin required.

A series of clinical trials in major U.S. burn centres have shown that the system is a significant advancement over the current standard of care for burn patients and offers benefits in clinical outcomes and cost savings.

Unsurprisingly, this has led to the company recording very strong sales growth in FY 2020. Last month it reported first quarter sales of A$7.9 million, up 165% on the prior corresponding period.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man looking at his laptop and thinking.
Share Market News

Why is the ASX 200 pumping the brakes before the weekend?

Australian investors don't have the appetite today, here's why.

Read more »

Miner and company person analysing results of a mining company.
Resources Shares

Buy one, sell the other: Goldman's verdict on these 2 ASX 200 mining shares

The broker sees significant valuation differences between these 2 major ASX 200 mining shares.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why BHP, Lynas, Metals X, and Super Retail shares are dropping today

These shares are ending the week in the red.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Latin Resources, Newmont, Nick Scali, and ResMed shares are surging today

These ASX shares are ending the week strongly. But why?

Read more »

supermarket asx shares represented by shopping trolley in supermarket aisle
Mergers & Acquisitions

Metcash shares down despite corporate watchdog approval

Metcash is about to diversify and become a bigger business.

Read more »

happy investor, celebrating investor, good news, share price rise, up, increase
Capital Raising

Nick Scali share price jumps 14% to record high after raising $46m

Investors have responded very positively to the company's UK expansion plan.

Read more »

Three miners stand together at a mine site studying documents with equipment in the background
Materials Shares

BHP shares sink on $60b Anglo American takeover news

The Big Australian could be on the verge of a major acquisition.

Read more »